[
  {
    "ts": null,
    "headline": "Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering",
    "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced an advanced pharmacogenomic (PGx) laboratory test service designed to help providers understand the patient's individual genetic response to select drug therapies. This innovative offering aims to help providers determine appropriate medication on selection and dosing. It utilizes PGx information across a wide range of medical specialties including psychiatry, neurology, cardiology, oncology, rh",
    "url": "https://finnhub.io/api/news?id=3370bf512966034ab16c0b30cda5b17ac2d715b332d23f1b51d9517eef761d37",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756993920,
      "headline": "Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering",
      "id": 136642861,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced an advanced pharmacogenomic (PGx) laboratory test service designed to help providers understand the patient's individual genetic response to select drug therapies. This innovative offering aims to help providers determine appropriate medication on selection and dosing. It utilizes PGx information across a wide range of medical specialties including psychiatry, neurology, cardiology, oncology, rh",
      "url": "https://finnhub.io/api/news?id=3370bf512966034ab16c0b30cda5b17ac2d715b332d23f1b51d9517eef761d37"
    }
  },
  {
    "ts": null,
    "headline": "Q2 Earnings Highs And Lows: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting with Quest (NYSE:DGX).",
    "url": "https://finnhub.io/api/news?id=52e1bae20112fe4818ae2e6c8d34b2ebd98d0791166e86a964888b8d1d6c30d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756960546,
      "headline": "Q2 Earnings Highs And Lows: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks",
      "id": 136642862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting with Quest (NYSE:DGX).",
      "url": "https://finnhub.io/api/news?id=52e1bae20112fe4818ae2e6c8d34b2ebd98d0791166e86a964888b8d1d6c30d8"
    }
  }
]